Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H32FN9O2 |
Molecular Weight | 533.6005 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@]1(CC[C@@H](CC1)C2=NC(NC3=NNC(C)=C3)=CC(C)=N2)C(=O)N[C@@H](C)C4=CC=C(N=C4)N5C=C(F)C=N5
InChI
InChIKey=GBLBJPZSROAGMF-BATDWUPUSA-N
InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19-,27-/m0/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
840321
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
||
|
FDA ORPHAN DRUG |
634318
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
||
|
FDA ORPHAN DRUG |
728519
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2097132-94-8
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
129073603
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
C132295
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
HI-27
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
2394936
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
SUB196574
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
11004
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
100000182481
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
DTXSID901336540
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
Pralsetinib
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
1WPE73O1WV
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
1WPE73O1WV
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY | |||
|
Pralsetinib
Created by
admin on Sat Dec 16 13:23:00 GMT 2023 , Edited by admin on Sat Dec 16 13:23:00 GMT 2023
|
PRIMARY |
ACTIVE MOIETY